Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer

ClinicalTrials.gov ID: NCT00903240

Public ClinicalTrials.gov record NCT00903240. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 4:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3 Study of Bladder Cancer Recurrence Surveillance

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to detect recurrent bladder cancer using a combination of protein and DNA biomarkers in urine

Study identification

NCT ID
NCT00903240
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Predictive Biosciences
Industry
Enrollment
1,000 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2009 (Type not available)
Primary completion
Apr 2010 (Actual)
Completion
Oct 2010 (Actual)
Last update posted
Jun 8, 2011

2009 – 2010

United States locations

U.S. sites
20
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
BCG Oncology Phoenix Arizona 85032 —
Urology Associates Engelwood Colorado 80113 —
Atlantic Urological Associates Daytona Beach Florida 32114 —
Winter Park Urology Orlando Florida 32803 —
Metropolitan Urology Jeffersonville Indiana 47130 —
Mayo Validation Support Services Rochester Minnesota 55901 —
Metro Urology Woodbury Minnesota 55125 —
Associates in Urology/Urology Group of NJ 741 Northfield Avenue New Jersey 07052 —
Coastal Urology Associates Brick New Jersey 08723 —
Capital Regional Urological Surgeons Albany New York 12208 —
Community Care Physicians Albany New York 12208 —
University Urology Associates New York New York 10016 —
Hudson Valley Urology Poughkeepsie New York 12601 —
Associated Medical Professionals Syracuse New York 13210 —
The Urology Group Cincinnati Ohio 45212 —
Urological Associates of Lancaster Lancaster Pennsylvania 17601 —
Triangle Urologic Group Pittsburgh Pennsylvania 15212 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
Urology Clinics of North Texas Dallas Texas 75231 —
Urology San Antonio Research San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00903240, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 8, 2011 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00903240 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →